Renal Week 2009 - Secondary Hyperparathyroidism

If not, please take a few moments to fill out the form below. It’s free, and ensures that you receive regular alerts to the latest clinical news and other content.

Email*

Password*

Keep me logged in Forgot your password?

Email*

Renal Week 2009 Secondary Hyperparathyroidism Coverage

Researchers Link Elevated PTH to High Uric Acid

Eric Butterman November 01, 2009

Elevated serum parathyroid hormone levels are associated with higher serum uric acid levels in the U.S. adult population, investigators reported at ASN's Renal Week 2009.

Specialty Pharmacy Improves Control of Secondary Hyperparathyroidism

Eric Butterman November 01, 2009

Participation in a specialty pharmacy improved control of secondary hyperparathyroidism in hemodialysis patients, researchers reported at ASN's Renal Week 2009.

Cinacalcet Safely Treats Persistent Post-Kidney-Transplant Hyperparathyroidism

Eric Butterman November 01, 2009

Cinacalcet therapy is safe and effective for treating persistent hyperparathyroidism after renal transplantation, British researchers reported at ASN's Renal Week 2009. The medication is not associated with allograft dysfunction or significant adverse effects.

Elevated Parathyroid Hormone Linked to Obesity in CKD Patients

Eric Butterman November 01, 2009

Obesity in CKD patients is associated with increased parathyroid hormone levels independent of estimated glomerular filtration rate, according to a study presented at ASN's Renal Week 2009.

Ergocalciferol and Cholecalciferol Can Both Correct 25-Hydroxyvitamin D Deficiency

Jody A. Charnow October 31, 2009

Ergocalciferol 50,000 units per week and cholecalciferol 2,000 units per day can both correct 25-hydroxyvitamin D (25-OHD) deficiency within two months, but ergocalciferol recipients may achieve higher 25-OHD levels, according to researchers.

PTH Response to Calcitriol Reduced in African-American CKD Patients

Eric Butterman October 31, 2009

Among patients with stages III-IV CKD, African-American race is associated with a decreased parathyroid hormone response to oral calcitriol, according to a study presented at ASN's Renal Week 2009.

Loop Diuretics Raise Risk of Secondary Hyperparathyroidism

Eric Butterman October 31, 2009

Loop diuretics increase the risk of secondary hyperparathyroidism in CKD patients, but concurrent use of thiazide diuretics attenuate that risk, data suggest according to a study that was presented at ASN's Renal Week 2009.

Cinacalcet Effective for Refractory Hyperparathyroidism

Eric Butterman October 31, 2009

Cinacalcet showed long-term efficacy in reducing serum parathyroid hormone and calcium levels in renal transplant patients with refractory tertiary hyperparathyroidism, according to a study presented at ASN's Renal Week 2009.

Higher iPTH Does Not Hike Risk of Death, Cardiovascular Events

Eric Butterman October 30, 2009

Higher intact parathyroid hormone levels are not associated with all-cause mortality and cardiovascular events in CKD patients not yet on dialysis, researchers have concluded in a study that was presented at Renal Week 2009.

Vitamin D Insufficiency Common in Dialysis Patients with Secondary Hyperparathyroidism

Jody A. Charnow October 30, 2009

Nutritional vitamin D deficiency is widespread among hemodialysis patients with secondary hyperparathyroidism, and few receive nutritional vitamin D supplementation, according to a study presented at Renal Week 2009.

High iPTH Levels Increase the Risk of Death, Need for Renal Replacement Therapy

Jody A. Charnow October 30, 2009

Intact parathyroid hormone levels higher than 50 pg/mL in patients with stage 3 or 4 CKD are associated with an increased risk of death or the need for renal replacement therapy, data show according to a study presented at ASN's Renal Week 2009.

Alfacalcidol Vs. Calcidol for Secondary Hyperparathyroidism

Eric Butterman October 29, 2009

Oral alfacalcidol is effective in controlling secondary hyperparathyroidism with an adjusted dose 1.5 times that of oral calcitriol, a study showed.

Cinacalcet May Aid in Bone Remodeling After Renal Transplantation

Eric Butterman October 29, 2009

Cinacalcet treatment following renal transplantation is associated with improved bone remodeling, a study found.

Higher PTH Levels Associated with Heart Failure

Eric Butterman October 29, 2009

Among older adults, higher parathyroid hormone (PTH) levels are associated with heart failure and lower serum levels of 25-hydroxyvitamin D (25-OHD) are associated with all-cause mortality and myocardial infarction (MI).

Left Ventricular Hypertrophy Not Independently Linked to Vitamin D Deficiency

Eric Butterman October 29, 2009

The concentration of 25-hydroxyvitamin D (25-OHD) is not independently associated with left ventricular hypertrophy (LVH), researchers have concluded.